| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal HST16: Givosiran for treating acute hepatic porphyria |
|
Medicine details |
|
| Medicine name | givosiran (Givlaari®) |
| Formulation | subcutaneous injection |
| Reference number | 3939 |
| Indication | Treatment of acute hepatic porphyria (AHP) in adults and adolescents aged 12 years and older |
| Company | Sintetica Ltd |
| BNF chapter | Nutrition & blood |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 04/09/2020 |
| NICE guidance | |